Soliton (NSDQ:SOLY) announced today that it entered into a distribution and sales agreement with Aesthetic Solutions.
The agreement will see Aesthetic Solutions distribute Soliton’s rapid acoustic pulse (RAP) device and advanced design cartridges during a U.S. commercial launch targeted for the first half of 2021.
Get the full story at our sister site, Medical Design & Outsourcing.